In an astounding study the public has not heard about, the subcutaneous (under the skin) injection of just 1.6 milligrams of a thymus gland hormone (thymosin alpha-1) for seven days among patients with severe deathbed COVID-19 coronavirus disease dramatically increases T-cell counts and slashes the mortality rate by 272% (from 30% to 11%) without side effects.

This astonishing study, which emanates from Wuhan, China, the initial epicenter for the COVID-19 pandemic, indicates a life-saving remedy for severe COVID-19 coronavirus infections is at hand.  The report, published in the journal Clinical Infectious Diseases, is a landmark study because of its demonstrable effect even among the most severely ill patients facing imminent death.